PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24112413-2	2015	The objective of this study is to determine the prognostic significance of epidermal growth factor receptor (EGFR) expression (membrane and cytoplasmic) in resected PA and its correlation with lymph node metastasis and survival.	Protactinium	165-167	epidermal growth factor receptor	Homo sapiens	75-107	
27788491-11	2016	PA-MSHA-mediated inhibition of EGFR signaling and activation of the caspase pathway may play an important role in the induction of apoptosis in pancreatic cancer cells.	Protactinium	0-2	epidermal growth factor receptor	Homo sapiens	31-35	
27231631-2	2016	Anti-EGFR-GNs provided a significant enhancement in the PA signal in MDA-MB-231 tumor and the axillary LN metastases relative to MCF-7 tumor and non-LN metastases.	Protactinium	56-58	epidermal growth factor receptor	Homo sapiens	5-9	
24112413-2	2015	The objective of this study is to determine the prognostic significance of epidermal growth factor receptor (EGFR) expression (membrane and cytoplasmic) in resected PA and its correlation with lymph node metastasis and survival.	Protactinium	165-167	epidermal growth factor receptor	Homo sapiens	109-113	
20228837-8	2010	In conclusion, this study showed that the involvement of the mannose-mediated EGFR pathway has a critical function in the preclinical rationale for the development of PA-MSHA for the treatment of human breast cancer.	Protactinium	167-169	epidermal growth factor receptor	Homo sapiens	78-82	
32555693-8	2020	Adding pA to two lots of A431 cell lysates with high and low pTyr-EGFR allowed normalization and quantification of the latter by expressing results as density ratios for both 1D and 2D WB.	Protactinium	7-9	epidermal growth factor receptor	Homo sapiens	66-70	
16365240-6	2005	Epidermal growth factor receptor and ezrin expression in sodium butyrate (SB)-treated PA cell line PANC-1 was determined using immunocytochemistry.	Protactinium	86-88	epidermal growth factor receptor	Homo sapiens	0-32	
33260345-8	2020	EGFR mutations were detected in PA-TNA with 83% sensitivity and 100% specificity.	Protactinium	32-34	epidermal growth factor receptor	Homo sapiens	0-4	
30765854-5	2019	We present a combinatorial PIT approach for targeting BC expressing EGFR and HER2, using PA- labeled panitumumab (pan) and trastuzumab (tra), respectively.	Protactinium	89-91	epidermal growth factor receptor	Homo sapiens	68-72